Skip to content
Search

Latest Stories

NI pharmacies administer over 35,000 Covid-19 vaccines in first six weeks

The community pharmacy network across Northern Ireland has administered over 35,000 Covid-19 vaccines in the first six weeks of the roll-out.

Since the end of March, when 340 community pharmacies were given the green light, local pharmacies have seen a high demand for the vaccine, with many running out of their allocated supply within the first two weeks of the roll-out.


Gerard Greene, chief executive of Community Pharmacy NI, said: “Bringing community pharmacy into the Covid-19 vaccination programme has vastly improved access to the vaccine on the high streets of our towns, cities, and villages throughout Northern Ireland.

“Patients have had the option to receive their vaccine from a convenient and familiar health care professional, that they know and trust. The feedback we have been receiving is that patients really welcome the vaccine being available from pharmacies and that is tremendous endorsement for the service.

“Community pharmacies are the best places to reach the public including those in hard-to-reach communities and those in disadvantaged areas. With the level of pharmacies administering the vaccine, no eligible person should have far to travel to become protected against Covid-19.”

Local pharmacies are hoping to see a greater supply of the vaccine delivered to them in coming weeks as current levels of the AstraZeneca vaccine are low, with many community pharmacists seeing long waiting lists of patients emerging.

“Vaccine supply has been limited, and we thank the public for their patience while we wait for more supplies to be delivered. Once the supply improves, we expect numbers to grow further and are engaging with the Department of Health to ensure a greater amount of vaccine is supplied to community pharmacies,” Greene said.

“I would encourage anyone eligible to book your vaccine with your local community pharmacy.”

Community Pharmacist, Sheelin McKeagney, added: “It has been great to be able to vaccinate our own patients and the familiar faces that we see every day. We know many of our patients prefer not to travel too far to get their vaccine, particularly those in rural areas where it is just not as easy to get to larger vaccination centres.

“The one frustration has been having to turn some patients away due to the restricted amount of vaccine we have been supplied. Given our capacity to do this, we hope to see more vaccine become available in the coming weeks. We have a waiting list of people who want vaccinated by their local pharmacist and we want to fulfil that demand.

“Being part of the vaccine programme has been a real positive lift for both staff and our patients. Since the roll-out began, patients have commented that the convenience of getting the vaccine at their local pharmacy is a benefit as it means they can get vaccinated at a convenient time that suits them from a clinician they know locally. We are also delighted to be able to offer the vaccine as it means we are able to support our patients and relieve any concerns or anxieties they have.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less